Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 144

1.

Evaluation of the Influence of Gastrointestinal Co-Infections on Rotavirus Vaccine Effectiveness in Botswana.

Mokomane M, Tate JE, Steenhoff AP, Esona MD, Bowen MD, Lechiile K, Pernica JM, Kasvosve I, Parashar UD, Goldfarb DM.

Pediatr Infect Dis J. 2017 Nov 16. doi: 10.1097/INF.0000000000001828. [Epub ahead of print]

PMID:
29189612
2.

Preparing for rotavirus vaccine introduction - A retrospective assessment of the epidemiology of intussusception in children below 2 years of age in Nepal.

Rayamajhi A, Thapa A, Kumar M, Yen C, Tate JE, Parashar UD, Rayamajhi AK.

Vaccine. 2017 Nov 20. pii: S0264-410X(17)31581-5. doi: 10.1016/j.vaccine.2017.11.022. [Epub ahead of print]

PMID:
29169894
3.

Impact of rotavirus vaccine on acute gastroenteritis in children under 5 years in Senegal: Experience of sentinel site of the Albert Royer Children's Hospital in Dakar.

Diop A, Thiongane A, Mwenda JM, Aliabadi N, Sonko MA, Diallo A, Ndoye B, Faye PM, Ba ID, Parashar UD, Tate JE, Ndiaye O, Cissé MF, Ba M.

Vaccine. 2017 Nov 18. pii: S0264-410X(17)31469-X. doi: 10.1016/j.vaccine.2017.10.061. [Epub ahead of print]

PMID:
29162319
4.

Emergence of double- and triple-gene reassortant G1P[8] rotaviruses possessing a DS-1-like backbone post rotavirus vaccine introduction in Malawi.

Jere KC, Chaguza C, Bar-Zeev N, Lowe J, Peno C, Kumwenda B, Nakagomi O, Tate JE, Parashar UD, Heyderman RS, French N, Cunliffe NA, Miren IG; VACSURV Consortium.

J Virol. 2017 Nov 15. pii: JVI.01246-17. doi: 10.1128/JVI.01246-17. [Epub ahead of print]

5.

Early impact of rotavirus vaccination in children less than five years of age in Mozambique.

de Deus N, Chilaúle JJ, Cassocera M, Bambo M, Langa JS, Sitoe E, Chissaque A, Anapakala E, Sambo J, Guimarães EL, Bero DM, João ED, Cossa-Moiane I, Mwenda JM, Weldegebriel GG, Parashar UD, Tate JE.

Vaccine. 2017 Nov 8. pii: S0264-410X(17)31468-8. doi: 10.1016/j.vaccine.2017.10.060. [Epub ahead of print]

PMID:
29128381
6.

Rotavirus infection.

Crawford SE, Ramani S, Tate JE, Parashar UD, Svensson L, Hagbom M, Franco MA, Greenberg HB, O'Ryan M, Kang G, Desselberger U, Estes MK.

Nat Rev Dis Primers. 2017 Nov 9;3:17083. doi: 10.1038/nrdp.2017.83. Review.

PMID:
29119972
7.

Impact of rotavirus vaccine on rotavirus diarrhoea in countries of East and Southern Africa.

Weldegebriel G, Mwenda JM, Chakauya J, Daniel F, Masresha B, Parashar UD, Tate JE.

Vaccine. 2017 Oct 25. pii: S0264-410X(17)31458-5. doi: 10.1016/j.vaccine.2017.10.050. [Epub ahead of print]

PMID:
29102168
8.

Implementation of Rotavirus Surveillance and Vaccine Introduction - World Health Organization African Region, 2007-2016.

Mwenda JM, Burke RM, Shaba K, Mihigo R, Tevi-Benissan MC, Mumba M, Biey JN, Cheikh D, Poy MSc A, Zawaira FR, Aliabadi N, Tate JE, Hyde T, Cohen AL, Parashar UD.

MMWR Morb Mortal Wkly Rep. 2017 Nov 3;66(43):1192-1196. doi: 10.15585/mmwr.mm6643a7.

9.

National Estimates of Reductions in Acute Gastroenteritis-Related Hospitalizations and Associated Costs in US Children After Implementation of Rotavirus Vaccines.

Leshem E, Tate JE, Steiner CA, Curns AT, Lopman BA, Parashar UD.

J Pediatric Infect Dis Soc. 2017 Aug 10. doi: 10.1093/jpids/pix057. [Epub ahead of print]

PMID:
28992205
10.

Estimating global, regional and national rotavirus deaths in children aged <5 years: Current approaches, new analyses and proposed improvements.

Clark A, Black R, Tate J, Roose A, Kotloff K, Lam D, Blackwelder W, Parashar U, Lanata C, Kang G, Troeger C, Platts-Mills J, Mokdad A; Global Rotavirus Surveillance Network, Sanderson C, Lamberti L, Levine M, Santosham M, Steele D.

PLoS One. 2017 Sep 11;12(9):e0183392. doi: 10.1371/journal.pone.0183392. eCollection 2017.

11.

Rotavirus vaccine response correlates with the infant gut microbiota composition in Pakistan.

Harris V, Ali A, Fuentes S, Korpela K, Kazi M, Tate J, Parashar U, Wiersinga WJ, Giaquinto C, de Weerth C, de Vos WM.

Gut Microbes. 2017 Sep 11:1-9. doi: 10.1080/19490976.2017.1376162. [Epub ahead of print]

PMID:
28891751
12.

The effect of probiotics and zinc supplementation on the immune response to oral rotavirus vaccine: A randomized, factorial design, placebo-controlled study among Indian infants.

Lazarus RP, John J, Shanmugasundaram E, Rajan AK, Thiagarajan S, Giri S, Babji S, Sarkar R, Kaliappan PS, Venugopal S, Praharaj I, Raman U, Paranjpe M, Grassly NC, Parker EPK, Parashar UD, Tate JE, Fleming JA, Steele AD, Muliyil J, Abraham AM, Kang G.

Vaccine. 2018 Jan 4;36(2):273-279. doi: 10.1016/j.vaccine.2017.07.116. Epub 2017 Sep 2.

13.

Estimated reductions in hospitalizations and deaths from childhood diarrhea following implementation of rotavirus vaccination in Africa.

Shah MP, Tate JE, Mwenda JM, Steele AD, Parashar UD.

Expert Rev Vaccines. 2017 Oct;16(10):987-995. doi: 10.1080/14760584.2017.1371595. Epub 2017 Sep 4.

PMID:
28832219
14.

Early impact of rotavirus vaccine in under 5year old children hospitalized due to diarrhea, Swaziland.

Maphalala G, Phungwayo N, Masona G, Lukhele N, Tsegaye G, Dube N, Sindisiwe D, Khumalo L, Daniel F, Katsande R, Tate JE, Mwenda JM, Weldegebriel G.

Vaccine. 2017 Aug 1. pii: S0264-410X(17)30980-5. doi: 10.1016/j.vaccine.2017.07.072. [Epub ahead of print]

PMID:
28778615
15.

Evaluation of the Field Performance of ImmunoCard STAT!® Rapid Diagnostic Test for Rotavirus in Dadaab Refugee Camp and at the Kenya-Somalia Border.

Ope M, Nyoka R, Unshur A, Oyier FO, Mowlid SA, Owino B, Ochieng SB, Okello CI, Montgomery JM, Wagacha B, Galev A, Abdow A, Esona MD, Tate J, Fitter D, Cookson ST, Arunmozhi B, Marano N.

Am J Trop Med Hyg. 2017 Jun;96(6):1302-1306. doi: 10.4269/ajtmh.16-0885.

16.

Intussusception-related Hospitalizations Among Infants Before and After Private Market Licensure of Rotavirus Vaccines in Taiwan, 2001-2013.

Yen C, Shih SM, Tate JE, Wu FT, Huang YC, Parashar UD, Hsiung CA.

Pediatr Infect Dis J. 2017 Oct;36(10):e252-e257. doi: 10.1097/INF.0000000000001644.

PMID:
28640005
17.

Reduction in Diarrhea- and Rotavirus-related Healthcare Visits Among Children <5 Years of Age After National Rotavirus Vaccine Introduction in Zimbabwe.

Mujuru HA, Yen C, Nathoo KJ, Gonah NA, Ticklay I, Mukaratirwa A, Berejena C, Tapfumanei O, Chindedza K, Rupfutse M, Weldegebriel G, Mwenda JM, Burnett E, Tate JE, Parashar UD, Manangazira P.

Pediatr Infect Dis J. 2017 Oct;36(10):995-999. doi: 10.1097/INF.0000000000001648.

PMID:
28640001
18.

Impact and cost-effectiveness of rotavirus vaccination in Bangladesh.

Pecenka C, Parashar U, Tate JE, Khan JAM, Groman D, Chacko S, Shamsuzzaman M, Clark A, Atherly D.

Vaccine. 2017 Jul 13;35(32):3982-3987. doi: 10.1016/j.vaccine.2017.05.087. Epub 2017 Jun 13.

19.

Effectiveness of Rotavirus Vaccination: A Systematic Review of the First Decade of Global Postlicensure Data, 2006-2016.

Jonesteller CL, Burnett E, Yen C, Tate JE, Parashar UD.

Clin Infect Dis. 2017 Sep 1;65(5):840-850. doi: 10.1093/cid/cix369.

PMID:
28444323
20.

Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls.

Verani JR, Baqui AH, Broome CV, Cherian T, Cohen C, Farrar JL, Feikin DR, Groome MJ, Hajjeh RA, Johnson HL, Madhi SA, Mulholland K, O'Brien KL, Parashar UD, Patel MM, Rodrigues LC, Santosham M, Scott JA, Smith PG, Sommerfelt H, Tate JE, Victor JC, Whitney CG, Zaidi AK, Zell ER.

Vaccine. 2017 Jun 5;35(25):3295-3302. doi: 10.1016/j.vaccine.2017.04.037. Epub 2017 Apr 22. Review.

Supplemental Content

Loading ...
Support Center